Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

CompletedOBSERVATIONAL
Enrollment

86

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues
Trial Locations (22)

Unknown

Hospital Germans Trias i Pujol, Badalona

Hospital Universitario Bellvitge, L'Hospitalet de Llobregat

Complejo Hospitalario Universitario Santiago, Santiago de Compostela

Hospital Severo Ochoa, Leganés

Hospital Torrecárdenas, Almería

Hospital Clínic, Barcelona

Hospital del Mar, Barcelona

Hospital Universitario Vall d'Hebron, Barcelona

Hospital Universitario Reina Sofía, Córdoba

Hospital Puerta de Hierro, Madrid

Hospital Universitario Central de Asturias, Oviedo

Hospital de Navarra, Pamplona

Hospital Donosti, San Sebastián

Hospital Marqués de Valdecilla, Santander

Hospital Universitario Virgen de la Macarena, Seville

Hospital Universitario Virgen de Valme, Seville

Hospital Universitario Virgen del Rocío, Seville

Hospital Virgen de la Salud, Toledo

Hospital General Universitario de Valencia, Valencia

Hospital La Fe, Valencia

Hospital Clínico Universitario Lozano Blesa, Zaragoza

Hospital Miguel Servet, Zaragoza

All Listed Sponsors
lead

Fundación Pública Andaluza Progreso y Salud

OTHER

NCT02005146 - Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs | Biotech Hunter | Biotech Hunter